000 01713 a2200529 4500
005 20250515194202.0
264 0 _c20100113
008 201001s 0 0 eng d
022 _a1471-2407
024 7 _a10.1186/1471-2407-9-395
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLehmann, Annika
245 0 0 _aHigh class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo.
_h[electronic resource]
260 _bBMC cancer
_cNov 2009
300 _a395 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdenocarcinoma
_xenzymology
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Nucleus
_xgenetics
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aFemale
650 0 4 _aGene Expression
_xdrug effects
650 0 4 _aHistone Deacetylase 1
_xgenetics
650 0 4 _aHistone Deacetylase 2
_xgenetics
650 0 4 _aHistone Deacetylases
_xgenetics
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPancreatic Neoplasms
_xenzymology
650 0 4 _aTranscription Factor RelA
_xgenetics
700 1 _aDenkert, Carsten
700 1 _aBudczies, Jan
700 1 _aBuckendahl, Ann-Christin
700 1 _aDarb-Esfahani, Silvia
700 1 _aNoske, Aurelia
700 1 _aMüller, Berit Maria
700 1 _aBahra, Marcus
700 1 _aNeuhaus, Peter
700 1 _aDietel, Manfred
700 1 _aKristiansen, Glen
700 1 _aWeichert, Wilko
773 0 _tBMC cancer
_gvol. 9
_gp. 395
856 4 0 _uhttps://doi.org/10.1186/1471-2407-9-395
_zAvailable from publisher's website
999 _c19298788
_d19298788